| Med Works Urgent Care | |
|
3333 Massillon Rd Ste 102 Akron OH 44312-5982 | |
| (330) 896-3036 | |
| (330) 896-0464 |
| Full Name | Med Works Urgent Care |
|---|---|
| Speciality | Family Medicine |
| Location | 3333 Massillon Rd Ste 102, Akron, Ohio |
| Authorized Official Name and Position | Ivan Santoso (MEDICAL DIRECTOR/PRESIDENT) |
| Authorized Official Contact | 3308963036 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Med Works Urgent Care 3333 Massillon Rd Ste 102 Akron OH 44312-5982 Ph: (330) 896-3036 | Med Works Urgent Care 3333 Massillon Rd Ste 102 Akron OH 44312-5982 Ph: (330) 896-3036 |
| NPI Number | 1447363718 |
|---|---|
| Provider Enumeration Date | 08/17/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447363718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Ohio) | Primary |
News Archive
Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared to tamoxifen in premenopausal women with hormone receptor positive (HR+) early breast cancer, according to results reported at ESMO 2018 Congress in Munich.
Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke.
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
Dr. Katerina Johnson, who conducted her Ph.D. in the University's Department of Experimental Psychology, was researching the science of that 'gut feeling' - the relationship between the bacteria living in the gut (the gut microbiome) and behavioral traits.
› Verified 2 days ago
International Community Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 985 Gorge Blvd, Akron, OH 44310 Phone: 234-312-3607 | |
Summa Health Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 95 Arch St Ste 175, Akron, OH 44304 Phone: 234-867-7606 | |
Axesspointe Community Health Center Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 527 W Market St, Suite 100, Akron, OH 44303 Phone: 888-975-9188 | |
Bath Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #215, Akron, OH 44333 Phone: 330-665-8143 Fax: 330-668-1289 | |
Concentra Akron L.l.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1450 Firestone Parkway, Suite F, Akron, OH 44301 Phone: 330-724-3345 Fax: 330-724-5299 | |
Akron Internal Medicine Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1755 W Market St, Akron, OH 44313 Phone: 330-836-2828 Fax: 330-836-0959 | |
Summa Health Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1493 S Hawkins Ave Ste 130, Akron, OH 44320 Phone: 234-867-6828 |